Molecular Testing in Metastatic Gastric/GEJ Cancer

3 意见
administrator
administrator
06/30/23

David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个